openPR Logo
Press release

Tumor Ablation Market to become US$ 1.9 Billion by 2024

11-17-2017 07:07 AM CET | Health & Medicine

Press release from: Transparency Market Research

Tumor Ablation Market

Tumor Ablation Market

A recent study by Transparency Market Research (TMR) has detected that the competition in the global tumor ablation market is intense, in a fragmented scenario with the presence of a number of participants. That being said, there are plenty of growth opportunities too in the market for tumor ablation, which will continue to attract pharmaceutical companies and further intensify the competition. The TMR report projects the global tumor ablation market to witness a healthy growth rate of 12.20% during the forecast period of 2016 to 2024, reaching an estimated valuation of US$1.9 bn by 2024, considerably up from its evaluated worth of US$702.9 mn in 2015.

Technology-wise, this report segments the global tumor ablation market into microwave ablation, laser interstitial thermal ablation, high-intensity focused ultrasound, and radiofrequency ablation, which currently is the most profitable segment. The demand for radiofrequency segment is projected for a CAGR of 10.90% during the forecast period of 2016 to 2024, significantly exceeding the overall growth rate of the market for tumor ablation. This substantial demand for tumor ablation is a reflection of several benefits offered by the procedure, which is efficient, causes nominal damage to the tissues, and offers high-density focused ultrasound.

Read Report Overview @ https://www.transparencymarketresearch.com/tumor-ablation-market.html

Based on material, the report segments the global tumor ablation market into cancers of liver, lung, kidney, bone, breast, and prostate. Liver cancer is more common among men than women, and has significant demand, although lung cancer category is high profitable too, primarily as a result of changing lifestyle among the urban population.

Out of five regions analyzed by the report: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, the former accounted for nearly a third (30%) of the global demand in the tumor ablation market. In the near future, North America will continue to be the most lucrative region, gaining traction from factors such as high adoption rate of new technology, robust healthcare infrastructure, escalating geriatric population percentage, and high prevalence of cancer. Europe is another profitable region, although vastly populated Asia Pacific will turn into a highly profitable region as the technology goes cheaper and reaches widespread unmet demands.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18656

A number of factors are ensuring the prosperity of the global tumor ablation market in the near future, such as growing geriatric population across the world, technological advancements in ablation devices, increasing population base of cancer patients, which is a chronic disease, mushrooming number of hospitals, ablation centers, and surgical facilities across the globe, changing lifestyle, and government benefits for the companies indulging the in the research and development in this field. On the other hand, while cost constraints continue to hinder the proper progress of the market for tumor ablation, ongoing healthcare reforms is not supporting the current inflow of the demand.

Among the key vendors currently operating in the global tumor ablation market, is Medtronic plc. The company has a diverse product portfolio and continues to add new products as well as enhances the successful ones. Geographical expansion has also helped Medtronic to gain ground over its competitors. In the near future, some of the other prominent companies, such as Ethicon, Boston Scientific, and AngioDynamics, are expected to depend on product innovation to stay afloat in the fragmented and competitive landscape.

Buy Full Tumor Ablation Market Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=18656<ype=S

About Us

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Transparency Market Research
90 State Street, Suite 700, Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tumor Ablation Market to become US$ 1.9 Billion by 2024 here

News-ID: 820979 • Views:

More Releases from Transparency Market Research

Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive AI Adoption and Next-Generation Edge Computing Innovations | TMR
Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive A …
The global Neuromorphic Chip Market is entering a defining phase of exponential growth, propelled by a surge in artificial intelligence (AI) applications, edge computing expansion, and rapid advancements in next-generation semiconductor technologies. According to the latest industry analysis, the market-valued at US$ 56.2 Mn in 2023-is projected to expand at an extraordinary CAGR of 40.1% from 2024 to 2034, reaching an estimated US$ 2.3 Bn by 2034. Examine key highlights and
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological Disease Burden Accelerates | TMR
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological …
The global Neuroprotection Market continues to gain unprecedented momentum as healthcare systems worldwide intensify their focus on combating neurological disorders. With a valuation of US$ 31.6 Bn in 2022, the market is on track to reach US$ 60.1 Bn by 2031, expanding at a robust 7.5% CAGR during the forecast period. The rise in dementia, stroke, Parkinson's, epilepsy, and multiple sclerosis-combined with aging demographics and a surge in sedentary lifestyles-has
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Innovations in Gene Editing, Stem Cell Therapy, and AI-Based Neuromedicine | TMR
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Inn …
The global neuroregeneration therapy market continues to chart steady, sustained growth. The increasing incidence of neurological disorders-including Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, stroke, diabetic neuropathy, and spinal cord injuries-is significantly influencing market expansion. In 2023, the market was worth US$ 37.0 Bn, demonstrating rising demand for treatments capable of repairing or regenerating damaged neural tissue. Examine key highlights and takeaways from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86322 With breakthroughs
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Advances in Brain Mapping, AI, and Portable Neuroimaging | TMR
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Adv …
The global neuroscience market stood at US$ 30.1 Bn in 2022, reflecting the significant technological and clinical potential of neurological research. Projected to grow at a CAGR of 3.7% from 2023 to 2031, the industry is expected to reach US$ 41.6 Bn by 2031. Rising prevalence of neurodegenerative diseases, advancements in neuroimaging, integration of artificial intelligence, and the emergence of brain-computer interfaces are shaping the next decade of neuroscience innovation. Examine

All 5 Releases


More Releases for Tumor

Evolving Market Trends In The Carcinoid Tumor Industry: Advancements In Neuroend …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. What Is the Expected Carcinoid Tumor Market Size During the Forecast Period? In recent years, there has been a significant increase in the market size of carcinoid tumors, which is projected to expand from $1.61 billion in 2024 to $1.78 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.7%.
10-01-2024 | Health & Medicine
Getnews
Brain Tumor Foundation to Present Brain Tumor InfoCon, a Free Informational Prog …
Image: https://www.getnews.info/wp-content/uploads/2024/10/1727733338.jpeg Brain Tumor Foundation October 8 online presentations to feature world's leading experts discussing topics ranging from neuro-oncology trials to targeting metabolism in glioblastoma and cytokine microdialysis NEW YORK - The Brain Tumor Foundation [https://www.braintumorfoundation.org/] (BTF), the nation's premier non-profit dedicated to providing support and guidance for brain tumor patients and their families, today announced that it will be presenting Brain Tumor InfoCon [https://braintumorfoundation.org/resources/2798-2/], a free informational program for patients and caregivers.
Germ Cell Tumor Market - Revolutionizing Germ Cell Tumor Care: Next-Generation T …
Newark, New Castle, USA: The "Germ Cell Tumor Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Germ Cell Tumor Market: https://www.growthplusreports.com/report/germ-cell-tumor-market/8949 This latest report researches the industry structure,
Global Wilms Tumor Market
Global Wilms Tumor Market Analysis and Insights The wilms tumor market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.30% in the above-mentioned research forecast period. Ongoing research and products under clinical trials are the factors for the growth of the wilms tumor market. Request Access Global Wilms Tumor Market
Brain Tumor Treatment Market
Brain Tumor Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025 The global Brain Tumor Diagnosis and Treatments market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Brain Tumor Diagnosis and Treatments
Rising Prevalence of brain Tumor Couple with Geriatric Populations supporting gr …
Albany, NY, 26th February : Recent research and the current scenario as well as future market potential of "Brain Tumor Therapeutics: Global Markets to 2023" globally. ResearchMOZ.us has published a fresh report to its vast repository titled “Global Brain Tumor Therapeutics Market - Segmented by Type of Cancer and Therapeutics - Growth, Trends and Forecasts 2018-2026” to its offerings. The report provides comprehensive analysis of the global tumor therapeutics market in the